Edgewise Therapeutics, Inc. (EWTX) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alan J Russell

Chief Scientific Officer

—

$10.25M (6) scheduled

−$10.25M

31,466

0.0290%

$1.37M

+84.8%

Joanne M. Donovan

CMO

—

$4.62M (11) scheduled

−$4.62M

8,625

0.0079%

$374.38K

−53.9%

Badreddin Edris

Director

—

$3.40M (5) scheduled

−$3.40M

19,820

0.0182%

$860.32K

0.0%

Kevin Koch

President and CEO

—

$785.04K (3) scheduled

−$785.04K

52,488

0.0483%

$2.28M

+262.5%

Behrad Derakhshan

Chief Business Officer

—

$223.42K (4) scheduled

−$223.42K

31,826

0.0293%

$1.38M

+89.0%

John R Moore

General Counsel

—

$219.82K (4) scheduled

−$219.82K

17,697

0.0163%

$768.16K

+444.2%

Jonathan C Fox

Director

$199.40K (1)

—

+$199.40K

25,141

0.0231%

$1.09M

+131.6%

Peter A. Thompson

Director

—

443,792

0.4086%

$19.26M

—

Orbimed Advisors LLC entity

Director

—

443,792

0.4086%

$19.26M

—

R Michael Carruthers

Chief Financial Officer

—

86,162

0.0793%

$3.74M

+10.6%

Marc Semigran

Chief Development Officer

—

6,716

0.0062%

$291.52K

0.0%

Edgewise Therapeutics, Inc.

What the insiders did Mostly scheduled

By person